4-year-old battles eye cancer | Inquirer News

4-year-old battles eye cancer

Amiel Espinar

Amiel Espinar was just 2 years old when he was diagnosed in 2016 with retinoblastoma, a type of cancer that starts in the retina.

“The doctor advised me to go to Sorsogon so that the tumor in my son’s eye can be operated on immediately and stopped from affecting his brain,” Amiel’s father, Amale Espinar, a farmer from Camarines Norte province, told the Inquirer. A single parent, he has three other children.

Article continues after this advertisement

Last September, father and son went to Philippine Children’s Medical Center in Quezon City where Amiel underwent chemotherapy.

FEATURED STORIES

On Jan. 21 this year, the tumor in his eye was removed during an operation. Another 12 chemotherapy sessions has been recommended for Amiel, now aged 4. So far, he has completed just five sessions, each one costing P38,000.

“We are scheduled for an MRI test on July 24. If the results are good, the sixth chemotherapy session may be in August. I pray that God will continue to help us through you,” said Amale Espinar who can be reached at 0950-3634279. Deposits can be made to his Landbank account
(# 0596 1753 09).

Article continues after this advertisement

(Correction: In last week’s issue, the Landbank account number of Ricardo Moralita, father of patient John Casie Moralita, was incomplete. The complete number is 2916 0875 54.)

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: medical aid

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.